WALTHAM, Mass.–(BUSINESS WIRE)–Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical company focused on discovering, developing, and commercializing potential best-in-class medicines for serious and rare diseases, today announced that the C…
Category: Business
Intravitreal Injection of Retinal Progenitor Cells Shows Promise in Preclinical Study for Diabetic Retinopathy
IRVINE, Calif.–(BUSINESS WIRE)–A new preclinical study titled “Intravitreal Transplantation of Retinal Progenitor Cells Improves Outcome Measures in a Rat Model of Diabetic Retinopathy” reports that retinal progenitor cells (RPCs) may provide both fu…
Les troubles de la vision ne sont pas toujours évidents
OTTAWA, Ontario–(BUSINESS WIRE)–L’Association canadienne des optométristes (ACO) encourage les examens de la vue complets réguliers pour les enfants avec une nouvelle campagne.
Les troubles de la vision ne sont pas toujours évidents
OTTAWA, Ontario–(BUSINESS WIRE)–L’Association canadienne des optométristes (ACO) encourage les examens de la vue complets réguliers pour les enfants avec une nouvelle campagne.
Eye Issues Aren’t Always Obvious
OTTAWA, Ontario–(BUSINESS WIRE)–The Canadian Association of Optometrist (CAO) urges regular comprehensive eye exams for children with a new awareness campaign.
Terravet Real Estate Solutions Becomes Terramed Real Estate Solutions Amid Expansion Into High‑Need Medical Specialties
BALA CYNWYD, Pa.–(BUSINESS WIRE)–Terravet Real Estate Solutions rebrands as Terramed, expanding from veterinary into ophthalmology and fertility.
Lumata Health Improves Patient Adherence to Vision-Saving Treatments by Alleviating Barriers to Care
RALEIGH, N.C.–(BUSINESS WIRE)– #ContinuousCare–Lumata Health, the company focused on ending preventable blindness with continuous ophthalmic care for people facing chronic eye disease, today announced the results of its new research report, “Lumata’…
Alcon and STAAR Surgical Announce Expiration of Hart-Scott-Rodino Waiting Period for Alcon’s Acquisition of STAAR
GENEVA & LAKE FOREST, Calif.–(BUSINESS WIRE)–Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, and STAAR Surgical Company (NASDAQ: STAA) (“STAAR”), the manufacturer of the Implantable Collamer® Lens (IC…
GenSight Biologics Reports Interim Financial Results for the First Half of 2025
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and cent…
GenSight Biologics publie ses résultats financiers du premier semestre 2025
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext : SIGHT, ISIN : FR0013183985, éligible PEA-PME), société biopharmaceutique spécialisée dans le développement et la commercialisation de thérapies géniques innovantes pour les maladie…
Neurotech Granted Permanent J-Code (J3403) for ENCELTO™ (revakinagene taroretcel-lwey), Effective October 1, 2025
CUMBERLAND, R.I.–(BUSINESS WIRE)–Neurotech Pharmaceuticals, Inc., a private biotech company focused on developing transformative therapies for chronic eye diseases, today announced that the Centers for Medicare & Medicaid Services (CMS) has assig…
AR Breakthrough: SCHOTT achieves serial production of Geometric Reflective Waveguides
RYE BROOK, N.Y.–(BUSINESS WIRE)–International technology group SCHOTT, a leader in high-performance materials and optics, has achieved a breakthrough in high-volume production of Geometric Reflective Waveguides. This marks a key advancement for Augme…
Bausch + Lomb Will Release Third-Quarter 2025 Financial Results on Oct. 29 and Hold Investor Day on Nov. 13
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its third-quarter financial results on Wednesday, Oct. 29, 2025. The …
Glaukos Breaks Ground on New Research, Development, and Manufacturing Facility in Huntsville, Alabama
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today celebrated the …
Broadwood Partners Files Definitive Proxy Statement Soliciting STAAR Surgical Stockholders to Vote “AGAINST” Proposed Acquisition by Alcon
NEW YORK–(BUSINESS WIRE)–Broadwood Partners, L.P. and its affiliates (collectively, “Broadwood”), holders of approximately 27.5% of the outstanding common stock of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA) today announced that …
Horizon Surgical Systems Appoints Rajesh K. Rajpal, MD as Chief Strategy and Medical Officer
SANTA MONICA, Calif.–(BUSINESS WIRE)–Horizon Surgical Systems, a leader in surgical robotic platforms, appoints Rajesh K. Rajpal, MD as its Chief Strategy and Medical Officer (CSO & CMO).
Yunqi Capital, 5.1% Holder and One of STAAR Surgical Company’s Largest Shareholders, Announces Intention to Vote Against the Proposed Sale to Alcon
HONG KONG–(BUSINESS WIRE)–Yunqi Capital Limited (together with its affiliates and the funds it advises, “Yunqi Capital”), an investment management firm and 5.1% shareholder of STAAR Surgical Company (“STAAR”) (NASDAQ:STAA), today announced its opposi…
iVeena Awarded $2 Million National Eye Institute Grant to Advance Novel Therapy for Pediatric Myopia
SALT LAKE CITY–(BUSINESS WIRE)–iVeena Delivery Systems, Inc. (“iVeena”), a clinical-stage ophthalmology company, today announced it has been awarded a $2 million Phase 2 Small Business Innovation Research (SBIR) grant from the National Eye Institute …
Le Symposium 2025 sur les nouvelles technologies de la vision périphérique rétinienne et la première conférence clinico-universitaire VPR se sont conclus avec un grand succès.
PÉKIN–(BUSINESS WIRE)–Le 3 septembre 2025, le « Symposium 2025 sur les nouvelles technologies de la vision périphérique rétinienne et la première conférence d’échange clinico-universitaire sur la VPR » s’est tenu à Hangzhou Chine. Organisé par Beijin…
iCare Launches ALTIUS: The Game-Changing Cloud Platform Redefining Eye Care Imaging
RALEIGH, N.C.–(BUSINESS WIRE)–iCare USA, a global innovator in eye care diagnostics, proudly unveils the launch of iCare ALTIUS™, a sleek cloud platform that’s set to disrupt how eye care professionals capture, manage, and share diagnostic images. Bu…